Current recommendation for antimicrobial prophylaxis in cardiac surgery: cefazolin up to 72 hrs (prolonged use may increase antimicrobial resistance). In the setting of either a presumed or known Staphylococcal colonisation, the hospital presence of a high incidence of MRSA, patients susceptible to colonisation, or an operation for a patient having prosthetic valve or vascular graft insertion, it would be reasonable to combine the beta-lactam with a glycopeptide (vancomycin) for prophylaxis.
Special considerations in immunodeficient syndromes (DiGeorge Syndrome, postoperative – see chylothorax).
[1] Am J Infect Control 2010 Nov;38(9):706-710: Sohn et al: Risk factors and risk adjustement for surgical site infections in pediatric cardiothoracic surgery patients
[2] Pediatr Cardiol 2010 May;31(4): 483-9: Abou Elella et al: Impact of bloodstream infection on the outcome of children undergoing congenital heart surgery
[3] Am J Health Syst Pharm 2008 Nov 1;65(21): 2008, 2010: Survey of congenital heart surgeons’ preferences for antimicrobial prophylaxis for pediatric cardiac surgery patients
[4] Ann Thorac Surg 2007 Apr; 83(4): 1569-76: Engelman et al: The Society of thoracic surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, Part II: Antibiotic Choice
All Marc’s PICU cardiology FOAM can be found on PICU Doctor and can be downloaded as a handy app for free on iPhone or Android. A list of contributors can be seen here.
If you enjoyed this post, why not check out our online courses at DFTB Digital
Infection
Tags: infection
Marc Anders. Infection, Don't Forget the Bubbles, 2013. Available at:
https://doi.org/10.31440/DFTB.3764
Surgical site infection (superficial/deep/organ):
Blood stream infection:
Pulmonary infection:
Current recommendation for antimicrobial prophylaxis in cardiac surgery: cefazolin up to 72 hrs (prolonged use may increase antimicrobial resistance). In the setting of either a presumed or known Staphylococcal colonisation, the hospital presence of a high incidence of MRSA, patients susceptible to colonisation, or an operation for a patient having prosthetic valve or vascular graft insertion, it would be reasonable to combine the beta-lactam with a glycopeptide (vancomycin) for prophylaxis.
Special considerations in immunodeficient syndromes (DiGeorge Syndrome, postoperative – see chylothorax).
See also sepsis and fever.
References:
[1] Am J Infect Control 2010 Nov;38(9):706-710: Sohn et al: Risk factors and risk adjustement for surgical site infections in pediatric cardiothoracic surgery patients [2] Pediatr Cardiol 2010 May;31(4): 483-9: Abou Elella et al: Impact of bloodstream infection on the outcome of children undergoing congenital heart surgery [3] Am J Health Syst Pharm 2008 Nov 1;65(21): 2008, 2010: Survey of congenital heart surgeons’ preferences for antimicrobial prophylaxis for pediatric cardiac surgery patients [4] Ann Thorac Surg 2007 Apr; 83(4): 1569-76: Engelman et al: The Society of thoracic surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, Part II: Antibiotic ChoiceAll Marc’s PICU cardiology FOAM can be found on PICU Doctor and can be downloaded as a handy app for free on iPhone or Android. A list of contributors can be seen here.
About Marc Anders
View all posts by Marc Anders | Website